Protective Effect of ACE Inhibitors on Ischemia-Reperfusion-induced Arrhythmias in Rats: Is this Effect Related to the Free Radical Scavenging Action of these Drugs?

References

• Manning A. S., Hearse D. J. Reperfusioninduced arrhythmias: Mechanisms and prevention. Journal of Molecular and Cellular Cardiology 1984; 16: 497–518
   PubMed Web of Science ®Google Scholar
• Hearse D. J. Ischemia, reperfusion, and the determinants of tissue injury. Cardiovascular Drugs and Therapeutics 1990; 4: 767–76
   PubMed Web of Science ®Google Scholar
• Huang T. F. Drug effects on the ischemia‐ and reperfusion‐induced arrhythmias in the conscious rats. Chinese Journal of Physiology 1992; 35: 9–19
   Google Scholar
• Westlin W., Mullane K. Does captopril attenuate reperfusion‐induced myocardial dysfunction by scavenging free radicals?. Circulation 1988; 77: 130–39
   Google Scholar
• Di Napoli P., Di Gregorio G., De Sanctis F., Gallina S., Di Girolamo E., Trevi G. P., Barsotti A. The myocardial protective effects of cardiac tissue ACE inhibition in experimental ischemia‐reperfusion in isolated rat hearts. Cardiologia 1993; 38: 107–12
   Google Scholar
• Scholkens B. A., Linz W. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts. Clinical and Experimental Hypertension, A 1988; 10: 1259–70
   PubMed Web of Science ®Google Scholar
• Van Gilst W. H., De Graeff P. A., Wesseling H., De Langen C. D. J. Reduction of reperfusion arrhythmia in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: A comparison of captopril, enalapril and HOE 498. Journel of Cardiovascular Pharmacology 1986; 8: 722–28
   PubMed Web of Science ®Google Scholar
• Di Pasquale P., Paterna S., Cannizzaro S., Albano V., Valdes L., Licata G., Barone G. Captopril and glutathione before thrombolysis in acute myocardial infarction: a pilot study. Drugs under Experimental and Clinical Research 1992; 18: 401–6
   Google Scholar
• Muller C. A., Opie L. H., Peisach M., Pineda C. A. Chronic oral pretreatment with the angiotensin converting enzyme inhibitor, trandolapril decreases ventricular fibrillation in acute ischemia and reperfusion. Euroaean Heart Journal 1994; 15(7)988–96
   Google Scholar
• Kingma J. H., van Gilsi W. H., Peels C. H., Dambnnk J. H., Verheugt F. W., Wielenga R. P. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. European Heart Journal 1994; 15(7)898–907
   Google Scholar
• Walker M. J. A., Curtis M. J., Hearse D. J., Campbell R. W. F., Janse M. J., Yellon D. M., Cobbe J. M., Coker S. J., Harness J. B., Harron D. W. G., Higgins A. J., Julian D. G., Lab M. J., Manning A. S., Northover B. J., Parratt J. R., Riemersma R. A., Riva E., Russell D. C., Sheridan D. J., Winslow E., Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovascular Research 1988; 22: 447–55
   PubMed Web of Science ®Google Scholar
• Iskit A. B., Guc M. O. Comparison of sodium pentobarbitone and urethane anaesthesia in a rat model of coronary artery occlusion an reperfusion arrhythmias: interaction with L‐NAME. Pharmacological Research 1996; 33(l)13–18
   Google Scholar
• Olmez E., Birincioglu M., Aksoy T., Acet A. Effects of captopril on ischemia‐reperfusion‐induced arrhythmias in an in vivo rat model. Pharmacological Research 1995; 32(1/2)3741
   Google Scholar
• Chopra M., McMurray J., Stewart J., Dargie H. J., Smith W. E. Free radical scavenging: a potentially beneficial action of thiol‐containing angiotensin converting enzyme inhibitors. Biochemical Society Transactions 1990; 18: 1184–1185
   PubMed Web of Science ®Google Scholar
• Dzau V. J. Circulating versus local renin angiotensin system in cardiovascular homeostasis. Circulation 1988; 77: 113–14
   Google Scholar
• Hirsch A. T., Talsness C. E., Shunkert H., Paul M., Dzau V. J. Tissue‐spesific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circulation Research 1991; 69: 475–82
   PubMed Web of Science ®Google Scholar
• van Wijngaarden J., Tio R. A., van Gilst W. H., de Graeff P. A., de Langen C. D. J., Wesseling H. Basic pharmacology of ACE inhibitors with respect to ischemic heart disease: prostaglandins and bradykinin. European Heart Journal 1990; 11: 86–93
   Google Scholar
• Bhoola K. D., Figueroa C. D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacological Reviews 1992; 44: 1–80
   PubMed Web of Science ®Google Scholar
• Linz W., Scholkens B. A. Role of bradykinin in the cardiac effects of angiotensin‐converting enzyme inhibitors. Journal of Cardiovascular Pharmacology 1992; 20: 83–90
   PubMedGoogle Scholar
• Cachofeiro V., Sakakibara T., Nasjletti A. Kinins, nitric oxide, and the hypotemive effect of captopril and ramiprilat in hypertension. Hypertension 1992; 19: 138–45
   PubMed Web of Science ®Google Scholar
• Radomski M. W., Palmer R. M. J., Moncada S. The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. British Journal of Pharmacology 1987; 92: 639–46
   PubMed Web of Science ®Google Scholar
• van Gilst W. H., de Graeff P. A., Wesseling H., de Langen C. D. J. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: A comparison of captopril, enalapril, and HOE 498. Journal of Cardiovascular Pharmacology 1986; 8: 722–8
   PubMed Web of Science ®Google Scholar
• Hartman J. C., Wall T. M., Hullinger T. G., Shebuski R. J. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by bradykinin antagonist HOE 140. Journal of Cardiovascular Pharmacology 1993; 21: 996–1003
   PubMed Web of Science ®Google Scholar
• Opie L. H. The heart, physiology and metabolism. Raven Press, New York 1991
   Google Scholar
• Carlsson L., Abrahamsson T. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium. European Journal of Pharmacology 1989; 166: 157–64
   Google Scholar
• de Graff P. A., van Gilst W. H., Bel K., de Langen C. D. J., Kingma J. H., Wesseling H. Concentration‐dependent protection by captopril against myocardial damage during ischemia and reperfusion in closed chest pig model. Journal of Cardiovascular Pharmacology 1987; 9: 37–42
   Google Scholar
• Ferrari R., Ceconi C., Curello S., Cargnoni A., Alfieri O., Pardini A., Marzollo P., Visioli O. Oxygen free radicals and myocardial damage: protective role of thiol‐containing agents. American Journal of Medicine 1991; 91: 95S–105S
   PubMed Web of Science ®Google Scholar
• Arduini A., Mezzetti A., Porreca E., Lapenna D., DeJulia J., Marzio L., Polidoro G., Cuccurullo F. Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. Biochimica et Biophysica Acta 1988; 970(2)113–21
   Google Scholar
• Koerner J. E., Anderson B. A., Dage R. C. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygenderived free radicals: superoxide dismutase plus catalase, N‐2‐mercaptopropionyl glycine and captopril. Journal of Cardiovascular Pharmacology 1991; 17: 185–91
   PubMed Web of Science ®Google Scholar
• Bernier M., Hearse D. J., Manning A. B. Reperfusion induced arrhythmias and oxygen‐derived free radicals. Studies with “anti‐free radical” interventions and a free radical‐generating system in the isolated perfused rat heart. Circulation Research 1986; 58(3)331–40
   Google Scholar
• Coetzee W. A., Owen P., Dennis S. C., Saman S., Opie L. H. Reperfusion damage: free radicals mediate delayed membrane changes rather than early ventricular arrhythmias. Cardiovascular Research 1990; 24(2)156–64
   Google Scholar
• Grover G. J., Sleph P. G., Dzwonczyk S., Wang P., Fung W., Tobias D., Cushman D. W. Effects of different angiotensin‐converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection. Journal of Pharmacology and Experiniental Therapeutics 1991; 257(3)919–29
   PubMedGoogle Scholar
• Kilgore K. S., Homeister J. W., Sato P. S., Lucchesi B. R. Sulfhydryl compounds, captopril, and MPG inhibit complement‐mediated myocardial injury. American Journal of Physiology 1994; 266(1–2)H28–35
   Google Scholar
• Tanaka M., Ishibashi T., Imai S. Effects of two angiotensin converting enzyme inhibitors on the mechanical function and energy metabolism of isolated rat hearts. A nuclear magnetic resonance study with an active form of benazeprilat and captopril. Arzneimit‐telforschung 1990; 40(10)1082–6
   Google Scholar